Cargando…
Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
Molecular mechanisms of Trypanosoma cruzi (Tc)-induced Chagasic cardiomyopathy (CCM) are not well understood. The NO-cGMP-PKG1α pathway maintains cardiac homeostasis and inotropy and may be disturbed due to phosphodiesterase (PDE5)-mediated cGMP catabolism in CCM. To test this, C57BL/6 mice were inf...
Autores principales: | Wen, Jian-jun, Wan, Xianxiu, Thacker, John, Garg, Nisha Jain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065248/ https://www.ncbi.nlm.nih.gov/pubmed/27747306 http://dx.doi.org/10.1016/j.jacbts.2016.04.005 |
Ejemplares similares
-
Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012) -
Defects of mtDNA Replication Impaired Mitochondrial Biogenesis During Trypanosoma cruzi Infection in Human Cardiomyocytes and Chagasic Patients: The Role of Nrf1/2 and Antioxidant Response
por: Wan, Xianxiu, et al.
Publicado: (2012) -
Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015) -
Analysis of Iron Metabolism in Chronic Chagasic
Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019) -
The role of microRNA-572 in the proliferation and chemotherapeutic treatment of prostate cancer
por: Zang, Mingcui, et al.
Publicado: (2021)